Status:
COMPLETED
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
Lead Sponsor:
University Hospital, Ghent
Conditions:
Head and Neck Tumor
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study will evaluate the feasibility of higher and prolonged dose escalation concentrated in the intra-tumoral regions which are FDG-avid after two weeks of radiotherapy.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Head and neck tumor
- Aged \> 18 years
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00406289
Start Date
November 1 2006
End Date
February 1 2010
Last Update
September 6 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000